Adjuvant temozolomide: how long and how much?

Expert Rev Anticancer Ther. 2008 May;8(5):663-5. doi: 10.1586/14737140.8.5.663.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents, Alkylating / administration & dosage*
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / radiotherapy
  • Brain Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Dacarbazine / administration & dosage
  • Dacarbazine / analogs & derivatives*
  • Dacarbazine / therapeutic use
  • Drug Administration Schedule
  • Glioblastoma / drug therapy*
  • Glioblastoma / radiotherapy
  • Glioblastoma / surgery
  • Humans
  • Neoplasm Recurrence, Local
  • Survival Analysis
  • Temozolomide

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide